advertisement
Kurimoto T 10
Showing records 1 to 10 | Display all abstracts from Kurimoto T109734 Test-retest repeatability of the imo binocular random single-eye test and Humphrey monocular test in patients with glaucoma
Toyokuni H
Japanese Journal of Ophthalmology 2023; 67: 578-589
109855 Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study
Inatani M; Orii Y
Advances in Therapy 2023; 40: 4074-4092
109734 Test-retest repeatability of the imo binocular random single-eye test and Humphrey monocular test in patients with glaucoma
Sakamoto M
Japanese Journal of Ophthalmology 2023; 67: 578-589
109855 Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study
Iwasaki K
Advances in Therapy 2023; 40: 4074-4092
109734 Test-retest repeatability of the imo binocular random single-eye test and Humphrey monocular test in patients with glaucoma
Ueda K; Kurimoto T
Japanese Journal of Ophthalmology 2023; 67: 578-589
109855 Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study
Arimura S
Advances in Therapy 2023; 40: 4074-4092
109734 Test-retest repeatability of the imo binocular random single-eye test and Humphrey monocular test in patients with glaucoma
Yamada-Nakanishi Y
Japanese Journal of Ophthalmology 2023; 67: 578-589
109855 Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study
Sunagawa H
Advances in Therapy 2023; 40: 4074-4092
109734 Test-retest repeatability of the imo binocular random single-eye test and Humphrey monocular test in patients with glaucoma
Yamada-Nakanishi Y; Nakamura M
Japanese Journal of Ophthalmology 2023; 67: 578-589
109855 Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study
Shiokawa M; Inoue K; Sakono T; Sakono T; Kuwamura R; Yoshida A; Oi J; Kuwayama Y; Kano K; Kido N; Matsuyama A; Ozaki M; Abe H; Inoue C; Nakagawa S; Musashi K; Kanamori A; Lee J; Otani S; Aoki R; Tanabe H; Nakakura S; Suzuki K; Sagara T; Saito Y; Sameshima M; Urahashi M; Watanabe-Kitamura F; Inoue T; Kagaya F; Murai Y; Mori S; Ueda K; Kurimoto T; Yamada-Nakanishi Y; Yamada-Nakanishi Y; Nakamura M; Yamashita T; Ishiyama S; Manabe S; Takaki K; Hayashi K; Ishida A; Tsutsui A; Tsutsui A; Manabe K; Tanito M
Advances in Therapy 2023; 40: 4074-4092
